Fathom Therapeutics is a Series a-stage Biotechnology Research company based in New York, New York, United States with roughly 11-50 employees. Fathom Therapeutics's team spans 3 in data & analytics and 2 in engineering. Fathom Therapeutics is led by Huafeng Xu, Founder and CEO, alongside Jesus Izaguirre (Co-Founder and Chief Computational Scientist), Mandana H. (Chief Business Officer), Yujie Wu (Chief Technology Officer), Arie Zask (Head of Chemistry), Cheryl Koh (Head of Discovery Biology) and Asghar Razavi, PhD (Director).

Huafeng Xu is the CEO of Fathom Therapeutics, serving as Founder and CEO. Huafeng Xu leads the company and its executive team.

Fathom Therapeutics's leadership team is led by Huafeng Xu (Founder and CEO) and includes Jesus Izaguirre (Co-Founder and Chief Computational Scientist), Mandana H. (Chief Business Officer), Yujie Wu (Chief Technology Officer), Arie Zask (Head of Chemistry), Cheryl Koh (Head of Discovery Biology), Asghar Razavi, PhD (Director). Each runs a function within the company.

Fathom Therapeutics's team spans 3 in data & analytics and 2 in engineering. Each department reports up to the leadership team, as shown in the org chart above.

Fathom Therapeutics's data & analytics team has 3 people, making it the largest team at Fathom Therapeutics.

Fathom Therapeutics's engineering team has 2 people, making it the second-largest team at Fathom Therapeutics.

Fathom Therapeutics has 18 employees, of which 3 work in data & analytics and 2 in engineering.

Fathom Therapeutics is headquartered in New York, New York, United States.

Fathom Therapeutics is a Series a-stage company operating in Biotechnology Research.

To correct or remove a profile from Fathom Therapeutics's page, email info@insideorg.com with the name and page link. Verified requests are processed within a few business days.